Breast Cancer
Results of taxane class drug study in early stage breast cancer published
Published in Women's Health Weekly, June 30th, 2005
The study demonstrates that an adjuvant (after surgery) Taxotere (docetaxel) Injection Concentrate-based regimen showed a significant 28% reduction in risk of relapse (p=0.001) and a significant 30% reduction in the risk of death (p=0.008) after 55 months of follow-up in women with operable, node-positive breast cancer. The results were observed regardless of the nodal, hormone-receptor, menopausal and HER-2/neu status.
Conducted by the Breast Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Adiposity
Cause, possible treatment for abdominal fat in postmenopausal women found - At-Risk Populations
AIDS expert says global strategy needed to combat "feminization" of HIV/AIDS - Breast Cancer
Density of breast tissue appears directly correlated to tumor risk - Breast Cancer
Women tend to overestimate breast cancer risk - Disease Prevention
Exercise, weight control may help reduce risk of breast cancer - Addiction Medicine
Developing lung studied, expression and modulation of lynx1 clarified - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
